• Cytotrait Secures £3M Seed Funding to Advance Agricultural Gene-Editing Platform
Cytotrait - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCytotrait
Cytotrait logo

Cytotrait

0 followers

About Cytotrait

Cytotrait is a plant biotechnology company focused on developing novel agrigen traits by reprogramming chloroplast and mitochondrial genomes. Their proprietary MOSS system enables rapid, high-copy gene edits within organelles, achieving homoplasmy and localized, high-level expression in crops. The technology aims to enhance yields, resilience, and sustainability in agriculture, with potential applications across food security and environmental impact. Based in the agricultural biotech sector, Cytotrait positions itself at the forefront of organelle trait engineering for crop improvement.

Recent News

No recent news for this company.

Recent Deals

Cytotrait Secures £3M Seed Funding to Advance Agricultural Gene-Editing Platform

March 9, 2026

Key Facts

Employees

Unknown

Status

Private

Website

https://cytotrait.com